The aim of this study was to investigate the effect of levothyroxine replacement therapy on biomarkers of oxidative stress (OS) and systemic inflammation in patients with hypothyroidism.

After months of deliberation, and no formal offers from a buyer, Novartis has decided that its generics business Sandoz will be spun out into an independent company. The Swiss pharma group said ...

After hours: February 3 at 6:40:00 PM EST ...

Generic and biosimilar drug producer Sandoz has agreed a $265 million settlement that aims to put allegations of price-fixing brought in a Pennsylvania lawsuit behind it. The agreement – which ...

Some people prefer it because it provides both hormones directly, while synthetic medications like levothyroxine only provide T4. Healthcare providers may hesitate to prescribe Armour Thyroid due to ...